Jun 29, 2025, 09:16 | Blog

Chalothorn Wannaphut: Honored to Be The Top Winner in the Why I Research Challenge

Chalothorn Wannaphut, Internal Medicine Resident at John A. Burns School of Medicine, shared SciProfiles MDPI's…

Jun 22, 2025, 10:42 | Insight

Michael Chuong Highlighted Phase 3 PANOVA-3 Trial on TTFields in Locally Advanced Pancreatic Cancer

Michael Chuong, Vice Chair and Medical Director of the Department of Radiation Oncology at Miami…

Jun 22, 2025, 03:15 | Insight

Monzr AlMalki: Thrilled to Share ACCESS Study Publication on Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis

Monzr AlMalki, Director of Haploidentical Transplant Program at City of Hope, shared a post on…

Jun 20, 2025, 16:48 | Science

Eddie Cliff: COALITION Study Compares Results of Glofitamab Combinations in LBCL

Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared a post on X about…

Jun 19, 2025, 21:05 | Insight

New results from NMDP's groundbreaking ACCESS trial

NMDP shared a post on LinkedIn: "Big news: Peer-reviewed Journal of Clinical Oncology just published…

Jun 18, 2025, 15:13 | Insight

Nico Gagelmann: Closing the Gap - PTCy Boosts Survival After Mismatched Stem Cell Transplants

Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) and Chair of the…

Jun 18, 2025, 09:15 | Drugs

Raul Cordoba: Nivolumab-AVD vs Brentuximab Vedotin–AVD in Advanced-Stage Classic Hodgkin Lymphoma

Raul Cordoba, Chair of Community Stakeholder Committee at European Hematology Association (EHA), shared a post on X:…

Jun 12, 2025, 09:45 | Blog

Ramy Sedhom: Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults with Cancer

Ramy Sedhom, Clinical Director of Palliative Care at Penn Medicine Princeton Health, posted on X:…

Jun 12, 2025, 07:10 | Insight

Redefining "High-Risk" Multiple Myeloma with New Genetic Insights - International Myeloma Foundation

International Myeloma Foundation (IMF) shared a post on X about a paper by Nikhil C.…

Jun 9, 2025, 09:19 | Blog

Hassan Abushukair Shares ASCO25 Experience with JCO Poster Walks

Hassan Abushukair, Postdoctoral Researcher at OU Health Stephenson Cancer Center, posted on X: "It took…

Jun 5, 2025, 11:38 | Blog

Vincent Rajkumar: Photo of the year for Myeloma - Cilta-cel in Multi-Drug Refractory Disease

Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the…

Jun 5, 2025, 11:31 | Blog

Publication 101: Peer Review and Becoming a Successful Author - Journal of Clinical Oncology

Journal of Clinical Oncology shared a post on X: "Earlier today our journal editors shared…

Jun 3, 2025, 08:19 | Blog

Neeraj Agarwal Highlights Promising T-Cell Engager Data in Prostate Cancer at ASCO 2025

Neeraj Agarwal, Postdoctoral fellow at City of Hope, posted on X: "Just in from ASCO25.…

May 29, 2025, 02:24 | Insight

Stephen V Liu: Sequential CRT Benefit Over Concurrent IO and XRT in H&N SCC

Stephen V Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at…

May 28, 2025, 07:50 | Blog

FDA Oncology - Overall Survival and PARP Inhibitors in Advanced Ovarian Cancer

FDA Oncology posted on X: "FDA article outlines the decision-making process and rationale behind removal…

May 22, 2025, 16:17 | Science

Hematopoietic Stem Cell Transplantation Outcomes for High-Risk Acute Myeloid Leukemia

St. Baldrick's Foundation shared a post on LinkedIn: "New research published in the Journal of…

May 12, 2025, 05:08 | Blog

Eric Winer on ways to address burnout and improve well-being - ASCO

American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: "Burnout among oncology and…

May 11, 2025, 15:32 | Science

Shankar Siva: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases

Shankar Siva, Radiation Oncologist at Peter MacCallum Cancer Centre, shared a post on X: "…

May 10, 2025, 09:40 | Blog

Promising New Drug Combination for Colon Cancer Resistant to Standard Treatments

City of Hope shared a post on LinkedIn: "A Phase 3 clinical trial shows promise…

May 6, 2025, 18:07 | Blog

Vincent Rajkumar on Strengthening Career Pathways in Academic Oncology

Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared a post on…

May 6, 2025, 17:21 | Science

Megan E. Tesch: Improving Endocrine Therapy Adherence in Breast Cancer

Megan E. Tesch, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post on X…

May 5, 2025, 12:44 | Science

Aaron Goodman on Timing of BTKi Use in Mantle Cell Lymphoma

Aaron Goodman, Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, shared an…

Apr 18, 2025, 23:42 | Insight

Liquid Biopsy at Baseline Adds Prognostic and Predictive Value in mCRC - International Society of Liquid Biopsy

International Society of Liquid Biopsy shared a post on X: "Liquid Biopsy at Baseline Adds…

Apr 15, 2025, 14:40 | Blog

Pournima Kale: My top 5 picks that transformed my publication journey

Pournima Kale, Assistant Professor at Government Medical College and Hospital, shared a post on LinkedIn: "I…

Apr 15, 2025, 02:13 | Insight

Ruchika Talwar: Drug Shortages Demand Action - Policy Changes to Protect Patient Care

Ruchika Talwar, Medical Director, Office of Episodes of Care, Population Health at Vanderbilt University Medical…

Apr 14, 2025, 17:39 | Science

Marwan Fakih: Meaningful clinical benefits for KRAS G12C MCRC

Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on…

Apr 12, 2025, 06:25 | Blog

Mikkael A. Sekeres: New Journal of Clinical Oncology Cancer Stories podcast just dropped!

Mikkael A. Sekeres, Chief of the Division of Hematology at Sylvester Comprehensive Cancer Center, shared…

Apr 7, 2025, 19:22 | Insight

Nathan A. Pennell: Excited to have played a part in this exciting drug’s development

Nathan A. Pennell, Editor in Chief at American Society of Clinical Oncology (ASCO), shared on…

Mar 24, 2025, 16:23 | Insight

Luca Arecco: The updated ASCO Fertility Preservation Guidelines

Luca Arecco, Clinical Research Fellow at ESMO, shared a post on Twitter: "The updated ASCO…

Mar 18, 2025, 16:54 | Positive

The launch of the official JCO Journals LinkedIn page

JCO Journals shared a post on LinkedIn: "We're thrilled to announce the launch of the…

Mar 10, 2025, 08:54 | Blog

Martin Kaiser: Co-occurrence of more than 2 HRCAs is associated with highest unmet need in NDMM and RRMM

Martin Kaiser, Reader in Molecular Haematology at The Institute of Cancer Research, shared an article…

Mar 2, 2025, 10:58 | Oncologist Near Me

Oncologist Near Me – Lidia Schapira: A Leader in Cancer Care and Medical Education

Welcome to OncoDaily‘s special section “Oncologist Near Me” where we introduce prominent oncologists from around the…

Feb 28, 2025, 15:34 | Blog

CancerWorld welcomes their Co-Editors-in-Chief

CancerWorld shared a post on LinkedIn: "A New Era for CancerWorld: Welcoming Our Co-Editors-in-Chief. We…

Feb 23, 2025, 18:34 | Blog

Study led by ICR and University of Leeds find that 'Double Hit' Myeloma Doubles Risk of Early Progression

The Institute of Cancer Research shared a post on LinkedIn: "NEW: Research led by ICR…

Feb 23, 2025, 10:27 | Science

James Davis: Ide-cel vs cilita-cel in R/R multiple myeloma

James Davis, Assistant professor & malignant hematology pharmacist at MUSC Hollings Cancer Center, shared an…

Feb 15, 2025, 22:55 | Societies

Highlights From Day 2 of ASCOGU25

The ASCO Genitourinary Cancers Symposium (ASCOGU25) is an annual event organized by the American Society of Clinical Oncology…

Feb 8, 2025, 16:29 | Blog

Aruni Ghose: Spotlight on Lung Cancer Disparities in India

Aruni Ghose, Co-Founder and Chief Medical Officer of OncoFlow, posted the following on LinkedIn about…

Jan 30, 2025, 10:48 | Blog

The potential of BOT/BAL for patients who previously had limited treatment options - Agenus

Agenus shared a post on LinkedIn: "Breaking News: Today, we announced the publication of new…

Jan 30, 2025, 08:44 | Science

Final analysis of the PRECIOUS phase 3 trial

Paolo Tarantino, Clinical Fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared an article by…

Jan 29, 2025, 14:11 | Blog

Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research

Daniel Jones, Medical Student at Touro University Nevada, posted on LinkedIn: "I had the privilege…

Jan 28, 2025, 11:35 | Science

Jennifer S. Buell: Breaking Barriers in Advanced Sarcoma Treatment

Jennifer S. Buell, President and Chief Executive Officer at MiNK Therapeutics, shared an article by…

Jan 26, 2025, 15:29 | Science

Pallawi Torka: Phase II Trial of Frontline Therapy for Older Adults with Hodgkin Lymphoma

Pallawi Torka, Assistant Attending at Memorial Sloan Kettering Cancer Center, shared a post on X…

Jan 25, 2025, 04:12 | Science

Jarushka Naidoo: De-Escalation Strategies With ICIs in NSCLC - Do We Already Have Enough Evidence?

Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin, shared a post on X about…

Jan 25, 2025, 03:21 | Insight

Senthil Kumar discusses the KEYNOTE-590 study on advanced esophageal cancer

Senthil Kumar, Medical Oncologist at Red Hills Chennai, shared a post on X about a…

Jan 20, 2025, 13:05 | Science

Armando Orlandi: The Lancet warns how health misinfo spreads faster in digital age!

Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, posted on X: "Cowabunga! Riding Breast…

Jan 19, 2025, 15:12 | Blog

Narjust Florez on the challenges and overwhelming sense of not belonging as a Latina in Medicine

Narjust Florez, Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist…

Jan 19, 2025, 07:17 | Science

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer

Dana-Farber’s Breast Oncology Center posted on X, about recent paper by Kevin Kalinsky et al.,…

Jan 18, 2025, 22:54 | Blog

Yakup Ergün: Patients' interests must always come first in clinical trials

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X by Bishal…

Jan 18, 2025, 08:44 | Science

Bishal Gyawali: Inferior Control Arms in Prostate Cancer Trials - The ARANOTE Trial

Bishal Gyawali, Associate Professor at Queen’s University, Kingston, posted on X about recent paper by…

Jan 17, 2025, 14:35 | Science

Elisa Agostinetto: The Preferable-Effect trial is now out

Elisa Agostinetto, Medical Oncologist at the Brussels University Hospital, posted on X, about recent paper…

Jan 16, 2025, 16:03 | Science

Estela Rodriguez: Updated analysis of CM816

Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group…

Jan 15, 2025, 17:14 | Insight

Elias Orouji: A comprehensive review of the application of CAR-T cell therapy in colorectal cancer

Elias Orouji, Epigenomics Lead at Princess Margaret Genomics Centre, shared a post X about a…

Jan 14, 2025, 19:05 | Science

Shaida Ouladan: Chimeric Antigen Receptor-T Cells in Colorectal Cancer

Shaida Ouladan, a Molecular Pathology Scientist, shared a recent article on LinkedIn: "I’m thrilled to…

Jan 13, 2025, 19:30 | Insight

Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline

A recent paper by Evan Yu, Professor at the University of Washington, was mentioned by…

Jan 11, 2025, 16:54 | Insight

Patrick Forde: Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer

Patrick Forde, Professor at Johns Hopkins University, shared a post on X about a recent…

Jan 10, 2025, 06:50 | Science

Iván R. González: Does neoadjuvant immunotherapy outperform chemotherapy in resectable lung cancer?

Iván R. González, Medical Oncologist at the Comprehensive Cancer Center, Hospital Ángeles Puebla, posted on…

Jan 8, 2025, 11:44 | Blog

Andrea Necchi: Journal of Clinical Oncology⁩ Top Articles of 2024

Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared on X: "You cannot…

Jan 7, 2025, 18:04 | Insight

Stephen Liu: What is the best way to assess response of brain metastases to systemic treatment?

Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:…

Dec 24, 2024, 18:06 | Blog

Elvina Almuradova: ESPAC4 Long-Term Results in Journal of Clinical Oncology

Elvina Almuradova, Associate Professor at Medicana Health Group, shared a post on LinkedIn: “ESPAC4 Long-Term…

Dec 24, 2024, 14:02 | Science

Stephanie Graff: Abemaciclib Plus Fulvestrant in Advanced Breast Cancer

Stephanie Graff, Director of Breast Oncology at Brown University Health, posted on X about recent…

Dec 23, 2024, 12:23 | Science

Paolo Tarantino: PostMONARCH is out in Journal of Clinical Oncology

A recent paper by Kevin Kalinsky, Director of the Glenn Family Breast Center at Winship,…

Dec 22, 2024, 17:23 | Science

Zeynep Irem Ozay: Assessing nectin-4 as a predictive biomarker in GU malignancies

Zeynep Irem Ozay, Postdoctoral Research Fellow at Huntsman Cancer Institute, posted on X about recent…

Dec 22, 2024, 17:18 | Science

Sam Klempner: Proof of principle in KRAS G12C mutation in colorectal cancer

Sam Klempner, Associate Professor at Harvard Medical School, posted on X about recent paper by…

Dec 22, 2024, 07:59 | Science

Ilana Schlam: The BRIDGES study is out

Ilana Schlam, Assistant Professor of Medicine at Tufts University Medical Center, shared on X about…

Dec 17, 2024, 01:39 | Insight

Akhil Santhosh: The 3-year results of RELATIVITY 047 out in Journal of Clinical Oncology

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post…

Dec 17, 2024, 01:16 | Blog

Paolo Tarantino: LAG3 blockade adds upon PD1 blockade in melanoma

Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute, shared a post by Akhil Santhosh,…

Dec 13, 2024, 15:35 | Blog

Barend Sikkema: Body weight gain associated with alectinib in patients with ALK positive NSCLC

Barend Sikkema, PHD Candidate at Erasmus MC, shared a recent article on LinkedIn: "Publication Alert.…

Dec 12, 2024, 13:36 | Blog

The INDEPSO ISPSM Consensus on Management of Colorectal Peritoneal Metastases

INDEPSO posted on X about recent paper by Swapnil Patel et al., titled "INDEPSO-ISPSM Consensus…

Dec 8, 2024, 23:02 | Blog

Omnia Korani: I have completed my first manuscript review for the Journal of Clinical Oncology

Omnia Korani, Assistant Lecturer at National Cancer Institute, posted on LinkedIn: "Exciting Milestone I’m thrilled…

Dec 7, 2024, 16:57 | Blog

Ramy Sedhom: Emphasizing bereavement education in oncology

Ramy Sedhom, Assistant Professor of Hematology and Oncology at Perelman School of Medicine, posted the…

Dec 7, 2024, 02:54 | Insight

Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia

Jonathan Friedberg, Director of Wilmot Cancer Institute, shared a recent article by Petra Langerbeins on…

Dec 1, 2024, 14:00 | Blog

Jennifer Plichta: Online Calculator for Prognosis of De Novo Metastatic Breast Cancer

Jennifer Plichta, Director of Breast Risk Assessment Clinic at Duke University Health System, shared on X:…

Nov 13, 2024, 08:51 | Insight

Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing

Ben Westphalen, Oncologist with a specialization in Precision Oncology and Serving as chair of the…

Nov 11, 2024, 03:48 | Insight

Trastuzumab Deruxtecan in Advanced Solid Tumors With HER 2 Amplification Identified

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, shared an…

Nov 10, 2024, 14:56 | Blog

Pamela Kunz: Disrupting GI Oncology: Shattering Barriers with Inclusive Science

Pamela Kunz, Director of the Center for Gastrointestinal Cancers at Yale Cancer Center, shared a post…

Nov 10, 2024, 03:29 | Insight

Harold J. Burstein: Anthracyclines in Early Breast Cancer - The Long Goodbye

Harold J. Burstein, Breast Cancer Specialist and Professor at Harvard Medical School, shared a recent…

Nov 9, 2024, 15:58 | Insight

Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic PDAC

Arndt Vogel, Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School,…

Nov 7, 2024, 14:53 | Career

Rana McKay - Candidate for ASCO Nominating Committee

Rana McKay has been nominated as the Undesignated Member Candidate of the nomination committee for…

Nov 1, 2024, 17:31 | Insight

Francisco Esteva: ADCs are making waves in the fight against advanced HER2+ breast cancer

Francisco Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital,…

Oct 26, 2024, 10:44 | Blog

Laura Vater: JCO podcast about grief and the power of colleagues who support one another

Laura Vater, Gastrointestinal oncologist at the IU Simon Comprehensive Cancer Center, shared a post on…

Oct 25, 2024, 14:25 | Insight

Aaron Mitchell: New findings on cancer care quality for low-income Medicare patients

Aaron Mitchell, Medical Oncologist and Health Services Researcher at Memorial Sloan Kettering Cancer Center, shared…

Oct 16, 2024, 14:49 | Blog

Oncology Accelerated Approval Confirmatory Trials - FDA

FDA posted on LinkedIn about recent paper by Gautam Mehta and Richard Pazdur, titled "Oncology Accelerated Approval…

Oct 16, 2024, 08:41 | Blog

Gertjan Rasschaert: Salvage surgery for unifocal metastatic dMMR GI cancer responding to ICI

Gertjan Rasschaert posted on LinkedIn about recent paper by him as co-author, titled "Salvage Surgery…

Oct 15, 2024, 16:40 | Insight

First-Line Procarbazine, CCNU, and Vincristine With Radiotherapy in IDH-Mutant Oligodendroglioma - Journal of Clinical Oncology

Journal of Clinical Oncology shared a post on X: "Survival Outcomes Associated With First-Line Procarbazine, CCNU,…

Oct 11, 2024, 17:58 | Insight

Jarushka Naidoo: Randomized Phase II Trial Osimertinib with or without Ramucirumab in 1st line EGFR+NSCLC

Jarushka Naidoo shared a post on X: "RAMOSE: Randomized Ph II Trial Osimertinib+/-Ramucirumab in 1L EGFR+…

Oct 11, 2024, 17:21 | Insight

Xiuning Le: Phase 2 RAMOSE osimertinib with or without ramucrimab in 1L EGFR+ NSCLC

Xiuning Le shared a post on X: "Newly online Journal of Clinical Oncology. Our randomized phase…

Oct 11, 2024, 16:32 | Blog

Jarushka Naidoo: Patient Enrollment to Industry vs Federally-funded Cancer Clinical Trials

Jarushka Naidoo shared a post on X, about recent paper published in Journal of Clinical…

Oct 9, 2024, 16:50 | Insight

Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile

Ghassan Abou-Alfa, Medical Oncologist, Memorial Sloan Kettering Cancer Center, shared a post on X: "Congratulations…

Oct 8, 2024, 15:41 | Insight

Elisa Agostinetto: Association between hormonal contraceptives and breast cancer risk in BRCA1 carriers

Elisa Agostinetto shared a post on X: “Out in Journal of Clinical Oncology: A pooled…

Oct 8, 2024, 12:58 | Blog

Maryam Lustberg: Diverse site participation is needed to promote equitable access to trials

Maryam Lustberg posted on LinkedIn about recent paper by M. Kelsey Kirkwood et al., titled…

Oct 5, 2024, 17:01 | Blog

Erman Akkus: Local therapy in oligometastatic pancreatic cancer

Erman Akkus posted on X about recent paper by Hannah J. Roberts et al., titled…

Oct 5, 2024, 08:28 | Insight

Ryan Nipp: Delivering High-Quality Cancer Care

Ryan Nipp shared a post on X about a recent paper by Larissa Nekhlyudov et…

Oct 4, 2024, 15:14 | Blog

Evolving Landscape of Metastatic Cancer Survivorship

Maryam Lustberg posted on X about recent paper by Julia Lai-Kwon et al., titled "Evolving…

Oct 3, 2024, 17:40 | Blog

Honoring Dr Stella Arakelyan and welcoming Dr Mark Lawler as ICC's New Research Lead

The Institute of Cancer and Crisis (ICC) shared a post on LinkedIn, adding: " On…

Oct 2, 2024, 15:22 | Blog

We are Physicians, and the interest of patients should be our priority, summarised by Yakup Ergün

Yakup Ergün, Medical Oncologist at Bower Hospital, shared an article by Fred Saad on X:…

Sep 29, 2024, 18:45 | Insight

Ishwaria Subbiah: Understanding what goal concordant care truly means

Ishwaria Subbiah shared a post on LinkedIn: "Goal-Concordant Care Now out in Journal of Clinical Oncology …

Sep 29, 2024, 15:43 | Blog

Paolo Tarantino: The ratio of enrollment to industry-sponsored trials has doubled between 2008-2022

Paolo Tarantino shared the following on X: “Out in JCO: the ratio of enrollment to…

Sep 27, 2024, 13:26 | Blog

Yara Abdou: Navigating Treatment pathways in Metastatic HR+ Breast cancer

Yara Abdou shared a post on X: "With the expanding arsenal of endocrine & targeted…

Sep 26, 2024, 15:41 | Blog

Mark Lewis: The 'trolley problem' of adjuvant chemotherapy in colon cancer

Mark Lewis shared a post on X, about paper published in Journal of Clinical Oncology:…

Sep 26, 2024, 15:35 | Blog

Jarushka Naidoo: TL01 Phase III Datopotamab-Deruxtecan vs Docetaxel in second-line NSCLC

Jarushka Naidoo shared a post on X, about recent paper published in Journal of Clinical…